Harrow Health (HROW) PT Lowered to $62 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Price: $40.03 +2.98%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann analyst Jeffrey Cohen lowered the price target on Harrow Health (NASDAQ: HROW) to $62.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- Harrow Health (HROW) Misses Q2 EPS by 35c
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
